Impact of Connexins on Atherogenesis: A Brief Review by Myasoedova, Veronika A. et al.
  Journal of Integrative Medicine| Volume 07 | Issue 02 | December 2018
Distributed under creative commons license 4.0     DOI: https://doi.org/
ARTICLE
Impact of Connexins on Atherogenesis: A Brief Review
Veronika A. Myasoedova1, Dongwei Zhang2, Reinhard Wetzker3, Andrey V. Grechko4, Alexan-
der N. Orekhov1,5,6*
1. Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology,   Moscow 125315, Russia
2. Diabetes Research Center, Traditional Chinese Medicine School, Beijing University of Chinese Medicine, Beijing 
100029, China
3. Klinik für Anästhesiologie und Intensivmedizin Universitätsklinikum Jena, Austria
4. Federal Scientific Clinical Center for Resuscitation and Rehabilitation, Moscow, Russia
5. Institute for Atherosclerosis Research, Skolkovo Innovative Center, Moscow 121609, Russia
6. Centre of Collective Use, Institute of Gene Biology, Moscow 121552, Russia
ARTICLE INFO ABSTRACT
Article history
Received: 24th October 2018
Revised: 29th October 2018
Accepted: 15nd January  2019
Published: 31st January  2019
Connexins family in humans consists of 21 highly conserved proteins that 
are responsible for contact formation between cells. On the cell surface, 
connexins form hemichannels, or connexons. Two hemichannels brought 
together form a gap junction, a form of intercellular contact that allows 
for direct transfer of material and signals between the adjacent cells. Gap 
junctions serve for transporting ions and other soluble, low molecular 
weight molecules therefore synchronizing the microenvironment of the 
contacting cells and maintaining cell and tissue homeostasis. Impairment 
of gap junctions is associated with different pathological conditions. Im-
portantly, it has been described in atherosclerosis, which causes local cel-
lular dysfunction in the arterial wall tissues followed by the development 
of atherosclerotic plaque. There are 3 main connexins expressed in human 
cardiovascular system: Cx37, Cx40, and Cx43. Alterations in the arterial 
wall cells observed in atherosclerosis include changes in the expression 
pattern of the main connexins and impairment of intercellular contacts 
and communication. According to the currently available data, Cx37 and 
Cx40 have anti-atherogenic and vasculoprotective properties, while Cx43 
appears to be more pro-atherogenic. However, the effects of connexins 
are cell type-dependent and in many cases, remain to be studied in detail. 
In this review, we summarize the available knowledge on connexins of 
the arterial wall cells involved in atherosclerosis development.
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1. Introduction
Atherosclerosis remains one of the most challeng-ing and impactful disorders in the high-income countries, due to its high incidence, absence 
of symptoms in the preclinical period, severity of com-
plications that can immediately be lethal, and the lack 
of efficient therapy other than symptomatic. Among the 
consequences of atherosclerosis are myocardial infarction, 
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stroke, atherothrombosis, and sudden death.[1] Pathogen-
esis of atherosclerosis is complex and involves several 
pathological processes that merge at the level of the arteri-
al wall, namely dyslipidemia and presence of atherogenic 
modified low-density lipoprotein (LDL), inflammation, 
endothelial dysfunction and increased permeability, 
changes of the cellular structure of the arterial wall intima 
(neointimal formation) and active accumulation of lipids 
and cholesterol in the growing atherosclerotic plaque.[2] 
Advanced plaques are characterized by intraplaque neo-
vascularization, formation of the necrotic core, and thin-
ning or rupture of the protective fibrous cap, which can 
lead to thrombosis.[3] Atherosclerosis is generally known 
as age-related disease, although the early asymptomatic 
stages of pathogenesis are common in young adults.
Early stages of atherosclerotic lesion development are 
characterized by local dysfunction of the endothelial cells 
(ECs) that occurs most frequently at the sites of vascular 
system, where the laminar blood flow is perturbed: vessel 
bends or bifurcations. Areas of dysfunctional endotheli-
um have increased expression of adhesion molecules and 
pro-inflammatory factors, such as vascular cell adhesion 
protein 1 (VCAM1), E-selectin, or chemokine (C-C mo-
tif) ligand 2 (CCL2).[4] These areas are therefore prone to 
recruit circulating immune cells. Monocytes adhere to the 
lesion areas, penetrate into the vascular wall and take part 
in the lesion growth. Moreover, the affected endothelium 
is characterized by increased permeability,[4] leading to 
penetration of LDL particles into the intima. According 
to the current understanding, LDL is the major source of 
cholesterol and lipids that accumulate in the plaque. Once 
in the arterial wall, LDL particles can form complexes 
with the extracellular matrix components, such as proteo-
glycans, and undergo modifications, such as oxidation. 
These processes increase they atherogenicity (ability to 
induce the intracellular lipid accumulation). Modified 
atherogenic LDL particles, such as desialylated LDL or 
LDL-containing immune complexes, can also come from 
the circulation. Atherogenic LDL is engulfed by mac-
rophages and resident vascular wall cells that acquired 
phagocytic phenotype and, due to impaired reverse cho-
lesterol transport, is accumulating in the cytoplasm in a 
form of lipid droplets and cholesterol crystals. This results 
in the formation of foam cells that have cytoplasm filled 
with lipid inclusions. At the advanced stages, foam cells 
start dying, forming a necrotic core inside the plaque, 
which increases the risk of plaque instability.
Local inflammatory process and recruitment of the 
immune cells to the lesion site has a major contribution to 
the plaque growth.[5] However, resident cells also actively 
participate in the pathological process. Vascular smooth 
muscle cells (VSMCs) can undergo a phenotypic switch 
from the contractile to the “synthetic” phenotype, acquir-
ing increased motility and beginning to proliferate. As a 
result, growing neointima and increased production of the 
extracellular matrix add to the plaque volume. Finally, 
formation of a fibrous cap is characteristic of the advanced 
plaques. Such cap plays protective role, insulating the 
plaque and its necrotic core from the bloodstream.[6] Large 
atherosclerotic plaque can reduce the blood flow and 
cause chronic ischemia, however, rupture of the fibrous 
cap is even more dangerous, since it can provoke throm-
bus formation with sudden and fatal consequences due to 
the release of pro-thrombotic factors from the damaged 
plaque.[7] Plaque destabilization and rupture can be caused 
by the activity of the immune cells, such as macrophages 
neutrophils.[8]
Connexins are essential for maintaining intercellular 
communication and tissue homeostasis and their dys-
function is likely to play a role at the early stages of ath-
erosclerotic lesion development, notably at the stage of 
increased endothelial permeability. Loss of the endothelial 
barrier function is associated with changes in the expres-
sion of different connexins.[9] In this review, we will dis-
cuss the role of connexins in atherosclerosis.
2. Connexins, Connexons, and Gap Junctions
Connexins possess unique structural properties that 
allow them to form large transmembrane channels with 
high efficacy. Connexin hexamer forms a connexon, also 
known as a connexon hemichannel. A pair of such hemi-
channels on adjacent cells can come together to form a 
gap junction that connects their cytoplasms.[10] In a gap 
junction, connexins form stable head-to-head contacts 
(Figure1).
Figure 1. Structure of connexin channels. A) Connexin 
in the plasma membrane. B) Formation of a gap junction 
from two hemichannels.
Connexins are highly conserved proteins. In humans, 
21 members of the connexin family are known.[11] Con-
nexins contain a short cytoplasmic N-terminal domain, 
a regulatory C-terminal domain and four transmembrane 
domains separated by one cytoplasmic and two extracel-
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lular loops.[12] The nomenclature of connexins is based on 
their molecular mass, for instance, Connexin 43 (Cx43) 
has a molecular weight of 43 kDa. Gap junctions formed 
by connexins are essential for cell and tissue homeostasis 
and serve to exchange small molecular weight substances 
and signaling factors.[13] Connexons are important to para-
crine signaling, since they provide channels for releasing 
various molecules into the extracellular space.[14] Togeth-
er, connexins and connexons provide important means of 
intercellular communication, impairment of which is asso-
ciated with various pathologies, including atherosclerosis.
3. Connexins and Endothelial Dysfunction
Endothelial dysfunction, which precedes the formation 
of atherosclerotic lesions, can be caused by a spectrum 
of factors. Among them are hypercholesterolemia, high 
blood glucose, smoking, pro-inflammatory mediators 
and perturbed blood flow due to mechanical reasons. 
Affected ECs change their protein expression pattern, 
producing more adhesion molecules and less endothelial 
nitric oxide (NO) synthase (eNOS).[4] It is known that NO 
has protective properties in blood vessels by stimulating 
vasodilation, preventing inflammation, reducing adhesive 
activation of ECs, maintaining VSMCs in a quiescent 
state, and impeding aggregation of platelets.[15] Reduced 
NO production can trigger pathophysiological changes in 
the arterial wall. Moreover, dysfunctional ECs are charac-
terized by increased expression of pro-oxidant enzymes, 
such as NAPDH oxidase and xanthine oxidase, and re-
lease reactive oxygen species (ROS). This interferes with 
eNOS activity due to superoxide production.[16] At the 
same time, NO can be oxidized by ROS to peroxynitrite, a 
potent oxidant and nitrating agent,[17] which further aggra-
vates endothelial dysfunction.
In normal conditions, ECs mostly express connexins 
Cx37 and Cx40.[18] In atherosclerotic lesions, these con-
nexins are virtually absent, while expression of Cx43 is 
up-regulated in the plaque shoulder region.[19] Similar 
changes were observed in atherosclerosis-prone arterial 
regions, such as branching sites.[20] These changes of the 
connexin expression pattern can be induced, at least par-
tially, by pro-inflammatory factors. For instance, exposure 
to pro-inflammatory cytokine tumor necrosis factor (TN-
F)-α led to down-regulation of Cx37 and Cx40 expres-
sion in cultured ECs, while expression of Cx43 was only 
moderately affected.[21] In astrocytes, pro-inflammatory 
cytokines released by activated microglia suppressed gap 
junctions.[22] These observations suggest that the pro-in-
flammatory milieu of the atherosclerotic plaque can alter 
the expression of connexins in the arterial ECs.
It was found that Cx37 and eNOS colocalize and in-
teract on the EC membranes.[23] There is also a functional 
interplay between connexins and NO sognalling, since 
NO strengthens the endothelial barrier function by reduc-
ing the permeability of Cx37-containing gap junctions to 
small molecules.[24 Cx40 can also be found in close prox-
imity to the eNOS[25] and is important to its normal func-
tioning. In the arterial ECs of Cx40-deficient mice, eNOS 
expression was reduced along with decreased EC-depen-
dent vasodilation.[26] Therefore, endothelial connexins ap-
pear to be involved in the control of eNOS expression and 
function.
The expression of connexins by the ECs, including 
Cx37, can be influenced by hemodynamic forces.[27] Ar-
terial regions subjected to oscillatory shear stress (OSS) 
develop more stable lesions, while regions exposed to low 
laminar shear stress (LLSS) develop vulnerable plaques.[28] 
In Apolipoprotein (ApoE)-deficient mice, an experimental 
model of atherosclerosis, Cx37 deletion led to formation 
of plaques of a greater size compared with Cx37-express-
ing ApoE-deficient animals.[29]
Endothelial dysfunction is associated with increased 
expression of adhesion molecules such as vascular cell ad-
hesion molecule (VCAM)-1, intercellular adhesion mol-
ecule (ICAM)-1, P-selectin, and E-selectin. Tight control 
of the expression of adhesion molecules in necessary for 
normal functioning of the ECs and plays protective role. 
For instance, reduction of VCAM-1 expression by CD73/
ecto-5’-nucleotidase was shown to inhibit vascular in-
flammation and neointimal formation.[30] Endothelial-spe-
cific deletion of Cx40 in ApoE-deficient mice resulted in 
decrease of CD73 expression up-regulation of VCAM-1 
production leading to enhanced atherogenesis.[31]
The role of Cx43 in atherogenesis is less investigated, 
partly due to the very low or absent expression of this con-
nexin in normal arterial ECs. Offspring of platelet endo-
thelial cell adhesion molecule (PECAM)-1-deficient mice 
that had increased expression of Cx43 and ApoE-deficient 
mice had alleviated plaque progression.[32] A recent study 
reported that endothelial Cx43 modulates recruitment of 
monocytes through induction of expression of VCAM-
1 and ICAM-1.[33] Together, these observations indicate 
the diverse role of endothelial connexins in atherogenesis 
warranting further studies.
3.1 Role of Connexins in the Recruitment of Im-
mune Cells
It was shown that the expression of Cx43 in cultured 
human macrophages could be induced by treatment with 
interferon (IFN)-γ and TNF-α, which enhanced their phys-
iological responses.[34] High levels of Cx43 were observed 
in intraplaque macrophages and foam cells [19]. Monocyte 
Cx43 was shown to modulate monocyte-endothelial adhe-
sion through ATP release from monocytes into the extra-
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cellular space.[35] Despite these observations, to date there 
is no clear understanding of the role of Cx43 in monocyte/
macrophage involvement in atherogenesis.
More is known about the role of Cx37. Connexons 
formed by Cx37 can inhibit monocyte adhesion by releas-
ing ATP to the extracellular space. Accordingly, deficiency 
of this connexin in cultured monocytes was associated 
with a stronger adhesion to EC monolayers.[36] In mono-
cytes, the expression of this connexin is down-regulated 
by the exposure to oxLDL. This effect can be reversed 
by pretreatment with rutaecarpine, a cyclooxygenase-2 
(COX2) inhibitor.[37]
Neuthophils contain secretory granules which con-
tents release can cause tissue injury and atherosclerotic 
plaque destabilization. In atherosclerosis, pro-atherogenic 
role of neutrophils is particularly evident in early steps 
associated with endothelial dysfunction and induction of 
vascular inflammation and in late steps associated with 
plaque rupture and thrombus formation.[38] Recruitment 
of neutrophils to plaques is enhanced by hypercholester-
olemia that increases adhesion to the ECs, up-regulates 
granulopoiesis[39] and promotes neutrophil mobilization 
from the bone marrow.[40] Activation by pro-inflammatory 
stimuli such as lipopolysaccharide (LPS) or TNF-α induc-
es the expression of Cx43 in neutrophils and its trafficking 
to the plasma membrane.[41] In neutrophils, Cx43 may 
have anti-adhesive properties via release of ATP through 
Cx43-containing connexons, which initiates a signaling 
cascade leading to the inhibition of expression of adhesion 
molecules.[42] However, dysfunctional ECs may disturb 
these vasculoprotective effects and stimulate neutrophil 
recruitment to the lesions.
T lymphocytes are recruited to the arterial intima in a 
manner that is similar to that of monocytes.[43] The ma-
jority of T cells infiltrating the plaques are CD4-positive, 
although can belong to different subtypes and play dis-
tinct roles in the pathology. For example, Th1 cells have 
pro-inflammatory and pro-atherogenic effects mediated 
by inflammatory cytokines, such as interleukin (IL)-12, 
IFN-γ, and TNF-α. By contrast, Th2 cells are involved in 
the regulation of humoral immunity and suppressing of 
Th1-mediated responses through release of Th2 cytokines, 
such as IL-4, IL-5, and IL-13. The role of IL-17-produc-
ing Th17 cells in atherosclerosis can be controversial: 
at early stages, they can promote atherogenesis through 
IL-17-mediated recruitment of neutrophils, while at later 
stages, they may have a protective effect by inhibiting ac-
tivation of Th1 and expression of VCAM-1. Regulatory T 
cells (Tregs) are involved in immunosuppression via liber-
ation of anti-inflammatory cytokines IL-10 and transform-
ing growth factor (TGF)-β, which may have a protective 
effect.[44]
Peripheral blood T cells express Cx43. Expression of 
Cx40 was also detected but only in tonsil human T cell 
subpopulation.[45] Cx43 mediates formation of gap junc-
tions between T cells and dendritic cells in the immuno-
logical synapse. When T cell receptor (TCR) interacts 
with the complex of major histocompatibility complex 
(MHC) class II and an antigen, Cx43 accumulates at the 
synapse. Its blockage by mimetic peptides reduces T cell 
activation indicating for a prominent role of Cx43 in this 
process.[46]
Studies of mice lacking B or T cells provided evidence 
that antigen-specific adaptive immune responses are in-
volved in atherogenic process.[47] Some subsets of B cells 
can promote atherogenesis, for example, by producing IgE 
that leads to the activation of mast cells and macrophages.
[48] Like T cells, circulating B cells express Cx43, which is 
involved in their activation and adhesion upon formation 
of B-cell receptor (BCR) immunological synapse.[48] The 
Cx43 C-terminal domain is also essential for B cell motili-
ty and adhesion.[49][50] The majority of B cells are involved 
in the production of antibodies specific to lesion antigens. 
These antibodies are believed to exert anti-atherogenic 
effects. Therefore, Cx43-mediated activation of these cells 
may be atheroprotective.
3.2 Connexins and Platelet Aggregation
Platelets (or thrombocytes) are key players in driving 
inflammation and thrombosis.[51] Activated thrombocytes 
release factors that promote their adhesion to the ECs, 
neutrophils, monocytes, and lymphocytes. Platelets liber-
ate neutrophil and endothelial activators inducing produc-
tion of inflammatory cytokines. In addition, platelets form 
bridges between leukocytes and ECs mainly mediated by 
platelet P-selectin. In atherosclerosis, platelet-leukocyte 
aggregates promote the recruitment of inflammatory im-
mune cells to atherosclerotic plaques and atherothrombo-
sis.[52]
Platelets express different connexins, of which Cx37 is 
the most abundant. Cx37 and gap junctions were shown 
to regulate platelet aggregation forming intercellular tun-
nels that decrease tendency to thrombus formation.[53] In 
Cx37-deficient mice, platelet aggregation was reduced in-
dicating an important role for Cx37 hemichannels and gap 
junctions in platelet thrombus function.[54] Similarly, inhi-
bition of Cx40 in human platelets or its deficiency in mice 
reduces platelet aggregation, fibrinogen binding, granule 
secretion, and clot retraction.[55] Thus, platelet connexins 
seem to inhibit platelet activation that can be beneficial 
for delaying thrombus formation in atherosclerosis.
3.3 Connexins and Recruitment of Vascular 
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Smooth Muscle Cells
In atherosclerosis, VSMCs migrate from the media to 
the intima, where they proliferate and contribute to plaque 
growth and lipid accumulation. VSMC proliferation is in-
duced by various stimuli such as platelet-derived growth 
factor (PDGF). This is accompanied by phenotypic chang-
es in VSMCs that lead to the loss of contractility. VSMCs 
produce extracellular matrix proteins, including collagen, 
and form a fibrous cap above the plaque.[56] Vulnerable 
plaques usually have a thin fibrous cap that is relatively 
poor in collagen content and VSMC counts but enriched 
with macrophages. Macrophages secrete several matrix 
metalloproteinases (MMPs) that cleave collagen and 
destabilize the plaque. Additionally, these cells liberate 
pro-apoptotic factors, which induce VSMC death.[57] 
The phenotypic switch of VSMCs includes enhanced 
Cx43 expression and formation of more numerous gap 
junction of a larger size.[58] TGF-β, a key profibrotic factor, 
drives VSMC hyperplasia, induces production of collagen 
and other matrix proteins, and up-regulates Cx43 produc-
tion.[59] In porcine coronary artery SMCs, PDGF was able 
to promote phenotypic switch of spindle-shaped SMCs 
(characterized by a more contractile phenotype) to rhom-
boid SMCs that display superior migratory and prolifer-
ation properties compared with spindle-shaped SMCs.[60] 
PDGF stimulated Cx43 expression in spindle-shaped cells 
in parallel with suppression of Cx40 and α-smooth muscle 
actin expression.[61] In the early plaques, enhanced Cx43 
expression was also detected in humans[62] and rabbit[63] 
neointimal VSMCs. With plaque advancement, up-reg-
ulated Cx43 expression in VSMCs drops progressively.
[64] These observations indicate that intensive gap junction 
formation can be involved in synchronization of VSMC 
response to vascular injury, especially in the initial stage 
of restenosis. However, along with progression of athero-
sclerosis, Cx43 expression can progressively decline in 
aortal intimal cells thereby indicating increased motility 
of VSMCs. 
Expression of Cx43 is regulated by nuclear factor NF-
κB since binding of this transcription factor to the Cx43 
gene promoter was shown in arteries of mice with angio-
tensin II-induced hypertension. Accordingly, a positive 
correlation between Cx43 expression and NF-κB activa-
tion was observed in the radial artery of patients undergo-
ing coronary artery bypass graft surgery.[65] 
It is known that oxLDL can stimulate arterial VSMC 
phenotypic switch, proliferation, and migration.[66] Phos-
phorylation of Cx43 by oxidized phospholipids, which 
are active constituents of oxLDL, may contribute to this 
mechanism. Inhibition of VSMC proliferation by resvera-
trol to alleviate was associated with reduced phosphoryla-
tion of Cx43 indicating its potential importance in athero-
sclerosis.[67]
The impairment of intercellular accumulation upon 
atherosclerotic lesion development was reflected by the 
reduction of the number of intercellular contacts. With 
the help of the fluorescent dye transfer technique, it was 
found that cultured plaque aortal VSMCs possess signifi-
cantly lower number of gap junctions compared with cells 
originating from the normal (non-atherosclerotic) human 
aortas.[68]
4. Conclusion
To date, research was mainly focused on the role of 
three major vessel connexins: Cx37, Cx40, and Cx43. In 
general, it can be suggested that Cx37 and Cx40 possess 
anti-atherogenic properties by preventing monocyte adhe-
sion, platelet activation, and supporting quiescence of the 
arterial endothelium. The role of Cx43 appears to be more 
complex. This connexin probably plays a pro-atherogenic 
role in most of the cell types. However, in neutrophils, 
Cx43 was found to exert anti-adhesion activity. 
Development of hypercholesterolemic mice lacking 
specific connexins was very helpful for uncovering the 
role of these proteins in atherogenesis. However, findings 
obtained in animal models should be extrapolated to hu-
mans with caution. For example, stroke and myocardial 
infarction are almost absent in murine models. Lesion 
rupture with massive thrombosis is also a rare event in 
these models.
Additionally, the role of other gap junction proteins in 
atherosclerotic vessels is poorly understood. Since con-
nexins may exhibit even opposite roles in different cells, 
development of cell-specific connexin knock-out models 
is required to unravel an impact of each connexin in ath-
erogenesis.
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